Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial We analyzed ...
Adoptive immunotherapy harnesses the patient’s own or donor-derived lymphocytes to target and eradicate malignant cells. Central to this approach are T lymphocytes that are expanded, engineered or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results